Llanos, Baby Boy .
HRN: 23-76-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2023
AMPICILLIN 250MG (VIAL)
10/07/2023
10/13/2023
IV
135mg
Q12hrs
Potentially Septic Newborn
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes